Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2024-11-05 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve Notice is hereby given pursuant to ....
Regulatory Filings
2024-11-05 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document text is extremely short (561 characters) and consists solely of a digital signature block with no substantive content, financial data, or report information. There is no indication of a full report, announcement, or detailed filing. It appears to be a certification or attestation by an individual, likely an officer or authorized signatory. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2024-11-05 English
Intimation towards issue of duplicate shares certificate under SEBI LODR Reg, 2015.
Regulatory Filings
2024-10-22 English
Issue of Duplicate Share Certificate
Major Shareholding Notification Classification · 90% confidence The document contains a table listing shareholders, share numbers, certificate numbers, and date information. The content appears to be a record of share certificates or share ownership details. The document length is very short (456 characters), and there is no indication of financial results, management discussion, voting results, or regulatory announcements. This type of document is consistent with a Major Shareholding Notification or a similar share ownership disclosure. Given the presence of shareholder names and share counts, the best fit is Major Shareholding Notification (MRQ).
2024-10-22 English
Certificate pursuant to Reg 74(5) of SEBI (DP) Reg, 2018 for the quarter ended 30th Sept., 2024
Regulatory Filings
2024-10-08 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 90% confidence The document is very short (1094 characters) and contains no substantive financial data, analysis, or detailed report content. It appears to be a list or table of shareholder information, possibly related to share certificates or dematerialization details. There is no indication of a full report, audit, earnings release, or management discussion. The presence of names, folio numbers, and share certificate details suggests it is related to shareholding or share transactions but does not explicitly report a transaction or capital change. Given the lack of detailed financial or corporate governance content and the short length, this document best fits the category of Regulatory Filings (RNS) as a general miscellaneous filing that does not fit other categories.
2024-10-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.